Skip to main content

INVO Bioscience, Inc. (INVO)

NASDAQ: INVO · Delayed Price · USD
3.38
+0.10 (3.05%)
After-hours:Sep 23, 2021 5:31 PM EDT
3.28
-0.05 (-1.50%)
At close: Sep 23, 4:00 PM
Market Cap34.44M
Revenue (ttm)1.43M
Net Income (ttm)-9.85M
Shares Out10.50M
EPS (ttm)-1.22
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume58,734
Open3.29
Previous Close3.33
Day's Range3.25 - 3.39
52-Week Range2.90 - 12.30
Beta-1.14
AnalystsBuy
Price Target5.63 (+71.6%)
Est. Earnings DateNov 15, 2021

About INVO

INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. The company was founded in 2007 and is based in Sarasota, Massachusetts.

IndustryHealth Care Equipment & Supplies
Founded2007
Employees10
Stock ExchangeNASDAQ
Ticker SymbolINVO
Full Company Profile

Financial Performance

In 2020, INVO's revenue was $1.04 million, a decrease of -29.92% compared to the previous year's $1.48 million. Losses were -$8.35 million, 285.1% more than in 2019.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for INVO stock is "Buy." The 12-month stock price forecast is 5.63, which is an increase of 71.65% from the latest price.

Price Target
$5.63
(71.65% upside)
Analyst Consensus: Buy

News

INVO Bioscience Advances INVOcell® Commercialization Efforts With Acquisition in Canada

SARASOTA, Fla., Sept. 9, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®, an affor...

2 weeks ago - PRNewsWire

Dr. Inger Britt Carlsson, Vice President of Global Medical Affairs for INVO Bioscience, to Present at the 11th Annual...

SARASOTA, Fla., Sept. 3, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC), INVOcell®, announce...

2 weeks ago - PRNewsWire

Invo BioScience Inc. (INVO) Reports Q2 Loss, Lags Revenue Estimates

Invo BioScience Inc. (INVO) delivered earnings and revenue surprises of 10.53% and -0.95%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

INVO Bioscience Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update

SARASOTA, Fla., Aug. 16, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and develo...

1 month ago - PRNewsWire

Invo BioScience Inc. (INVO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Invo BioScience Inc. (INVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

INVO Bioscience to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021

SARASOTA, Fla., Aug. 5, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC), INVOcell®, an effect...

1 month ago - PRNewsWire

INVO Bioscience Announces First Joint-Venture Grand Opening Scheduled for August 9, 2021 in Birmingham, Alabama

SARASOTA, Fla., Aug. 2, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®, today ann...

1 month ago - PRNewsWire

INVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration

SARASOTA, Fla., July 14, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC), INVOcell®, an effec...

2 months ago - PRNewsWire

INVO Bioscience Signs Joint Venture Agreement with Bloom Fertility to Open an INVOcell Fertility Clinic in Atlanta

SARASOTA, Fla. and ATLANTA, June 30, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC), INVOcel...

2 months ago - PRNewsWire

INVO Bioscience Appoints Andrea Goren as Chief Financial Officer

SARASOTA, Fla., June 15, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOce...

3 months ago - PRNewsWire

New Strong Sell Stocks for May 21st

ATHM, INVO, FOUR, KRYS, and RMAX have been added to the Zacks Rank #5 (Strong Sell) List on May 21, 2021

Other symbols:ATHMFOURKRYSRMAX
4 months ago - Zacks Investment Research

INVO Bioscience Reports First Quarter 2021 Financial and Operating Results and Provides Business Update

SARASOTA, Fla., May 17, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and develop...

4 months ago - PRNewsWire

INVO Bioscience to Report First Quarter 2021 Financial Results on Monday, May 17, 2021

SARASOTA, Fla., May 11, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcel...

4 months ago - PRNewsWire

INVO Bioscience Appoints Meryle Lynn Chamberlain to Lead Marketing for Global Brand Expansion

SARASOTA, Fla., May 10, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcel...

4 months ago - PRNewsWire

INVO Bioscience Announces Appointment of Rebecca Messina to the Board of Directors

SARASOTA, Fla., April 26, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...

4 months ago - PRNewsWire

INVO Bioscience Joins in Supporting RESOLVE: The National Infertility Association During its National Infertility Awa...

SARASOTA, Fla., April 22, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...

5 months ago - PRNewsWire

INVO Bioscience Signs Partnership Agreement with Lyfe Medical to Establish INVOcell Clinic in Northern California

SARASOTA, Fla. and SAN FRANCISCO, April 19, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture S...

5 months ago - PRNewsWire

New Strong Sell Stocks for April 16th

VNET, ALTG, FPI, HALL, and INVO have been added to the Zacks Rank #5 (Strong Sell) List on April 16, 2021

Other symbols:ALTGFPIHALLVNET
5 months ago - Zacks Investment Research

INVO Bioscience to Present at Tribe Public Event on April 13, 2021

SARASOTA, Fla., April 12, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and devel...

5 months ago - PRNewsWire

INVO Bioscience Reports 2020 Financial Results

SARASOTA, Fla., March 30, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and devel...

5 months ago - PRNewsWire

INVO Bioscience to Present at the Lytham Partners Spring 2021 Investor Conference

SARASOTA, Fla., March 29, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...

5 months ago - PRNewsWire

INVO Bioscience to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Tuesday, March 30, 2021

SARASOTA, Fla., March 26, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...

5 months ago - PRNewsWire

INVO Bioscience to Participate in the 33rd Annual Roth Conference

SARASOTA, Fla., March 11, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...

6 months ago - PRNewsWire